Hall v. GLAXOSMITHKLINE, LLC

706 F. Supp. 2d 947, 2010 U.S. Dist. LEXIS 59962, 2010 WL 2473387
CourtDistrict Court, E.D. Missouri
DecidedJune 16, 2010
DocketCase No. 4:10CV965MLM
StatusPublished
Cited by1 cases

This text of 706 F. Supp. 2d 947 (Hall v. GLAXOSMITHKLINE, LLC) is published on Counsel Stack Legal Research, covering District Court, E.D. Missouri primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Hall v. GLAXOSMITHKLINE, LLC, 706 F. Supp. 2d 947, 2010 U.S. Dist. LEXIS 59962, 2010 WL 2473387 (E.D. Mo. 2010).

Opinion

706 F.Supp.2d 947 (2010)

Katherine B. HALL, et al., Plaintiffs,
v.
GLAXOSMITHKLINE, LLC, Defendant.

Case No. 4:10CV965MLM.

United States District Court, E.D. Missouri, Eastern Division.

June 16, 2010.

*948 Douglas P. Dowd, William T. Dowd, Dowd and Dowd, John J. Driscoll, Driscoll Firm, P.C., St. Louis, MO, for Plaintiffs.

Julia C. Walker, Shook Hardy & Bacon, LLP, Kansas City, MO, Matthew H. Noce, Gerard T. Noce, St. Louis, MO, for Defendant.

MEMORANDUM OPINION

MARY ANN L. MEDLER, United States Magistrate Judge.

Before the court is the Motion to Remand and Request for Expedited Consideration filed by Plaintiffs. Doc. 13. Defendant Glaxosmithkline, LLC, ("Defendant") filed a Response to Plaintiffs' Motion to Remand and Request for Expedited Consideration. Docs. 21. Also before the court is the Motion to Stay All Proceedings Pending Transfer by the Judicial Panel on Multidistrict Litigation filed by Defendant. Doc. 10. Plaintiffs filed a Response to Defendant's Motion and Defendant filed a Reply. Docs. 16, 24. The parties have consented to the jurisdiction of the undersigned United States Magistrate Judge pursuant to 28 U.S.C. § 636(c). Doc. 22.

BACKGROUND

This products liability action was filed by Plaintiffs in the Circuit Court of the City of St. Louis, Missouri. Plaintiffs alleged that Avandia, a prescription medication manufactured by Defendant, caused negative and detrimental effects on their hearts and cardiovascular systems. Defendant is a Delaware limited liability company. Plaintiff Kathryn B. Hall is a citizen and resident of Delaware and Plaintiff Mabrey Herndon is a citizen and resident of Missouri. Defendant removed this matter to the District Court for the Eastern District of Missouri. In its Notice of Removal, Defendant asserted that Plaintiffs claims are unrelated and that, although they each alleged they were injured by Defendant's product, Avandia, this medication was "prescribed at different times, by different doctors, in different states." Doc. 1 at 1. Defendant further asserted in the Notice of Removal that non-diverse Plaintiff Hall was fraudulently misjoined in an attempt to defeat federal jurisdiction; *949 that complete diversity exists between Plaintiff Herndon and Defendant; and that Plaintiff Hall's claims should be severed. Doc. 1 at 2.

Plaintiff argues, in support of its Motion to Remand, that In re Prempro Products Liability Litigation, 591 F.3d 613 (8th Cir. 2010), involved "an indistinguishable factual and procedural situation from the matter under consideration"; that in In re Prempro, the Eighth Circuit found that "the plaintiffs' alleged misjoinder ... was not so egregious as to constitute fraudulent misjoinder"; that In re Prempro is controlling; and that, therefore, this matter should be remanded to State court. Doc. 14 at 3.

LEGAL FRAMEWORK and DISCUSSION

28 U.S.C. § 1441 sets forth the grounds for removal from state court to federal court. Section 1441(a) provides, in pertinent part, that "any civil action brought in State court of which [federal district courts] have original jurisdiction, may be removed by the defendant" to federal district court. 28 U.S.C. § 1447(c) provides, in pertinent part, that: "A motion to remand the case on the basis of any defect other than lack of subject matter jurisdiction must be made within 30 days after the filing of the notice of removal under section 1446(a)."

28 U.S.C. § 1332(a) provides that "district courts shall have original jurisdiction of all civil actions when a matter in controversy ... is between (1) citizens of different states." "`Complete diversity of citizenship exists where no defendant holds citizenship in the same state where any plaintiff holds citizenship.'" In re Prempro, 591 F.3d at 620 (quoting OnePoint Solutions, LLC v. Borchert, 486 F.3d 342, 346 (8th Cir.2007)).

The party seeking the federal forum has the burden of pleading diversity of citizenship of the parties, Walker v. Norwest Corp., 108 F.3d 158, 161 (8th Cir. 1997), and the burden of establishing diversity jurisdiction by a preponderance of the evidence. Sheehan v. Gustafson, 967 F.2d 1214, 1215 (8th Cir.1992); Yeldell v. Tutt, 913 F.2d 533, 537 (8th Cir.1990); Russell v. New Amsterdam Cas. Co., 325 F.2d 996, 997 (8th Cir.1964). "[A]ll doubts about federal jurisdiction [are resolved] in favor of remand." Transit Cas. Co. v. Certain Underwriters at Lloyd's of London, 119 F.3d 619, 625 (8th Cir.1997). Thus, Defendant, as the party invoking removal jurisdiction, has the burden of establishing federal jurisdiction.

"When determining if a party has been fraudulently joined, a court considers whether there is any reasonable basis in fact or law to support a claim against a nondiverse defendant." In re Prempro, 591 F.3d at 620 (quoting Wilkinson v. Shackelford, 478 F.3d 957, 964 (8th Cir. 2007)). As noted by the Eighth Circuit in In re Prempro, 591 F.3d at 620, the theory of fraudulent misjoinder was first adopted by the Eleventh Circuit in Tapscott v. MS Dealer Service Corp., 77 F.3d 1353 (11th Cir.1996), abrogated on other grounds, Cohen v. Office Depot, Inc., 204 F.3d 1069 (11th Cir.2000). The court in Tapscott held that "[m]isjoinder may be just as fraudulent as the joinder of a resident defendant against whom a plaintiff has no possibility of a cause of action." 77 F.3d at 1360. See also Benjamin Moore & Co., 309 F.3d 296, 298 (5th Cir.2002) ("[M]isjoinder of plaintiffs should not be allowed to defeat diversity jurisdiction.").

The court in In re Prempro considered that Rule 20(a)(1) of the Federal Rules of Civil Procedure "allows multiple plaintiffs to join in a single action if (i) they assert claims "with respect to or arising out of the same transaction, occurrence, or series of transactions or occurrences;" and (ii) *950 "any question of law or fact common to all plaintiffs will arise in the action."" 591 F.3d at 622. The court further held that "Transaction," as used in Rule 20(a)(1), should be broadly construed. Id. In this regard, the court held:

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
706 F. Supp. 2d 947, 2010 U.S. Dist. LEXIS 59962, 2010 WL 2473387, Counsel Stack Legal Research, https://law.counselstack.com/opinion/hall-v-glaxosmithkline-llc-moed-2010.